Suppr超能文献

肾细胞癌的预后因素:巴西国家癌症研究所 227 例患者的分析。

Prognostic factors in renal cell carcinoma: analysis of 227 patients treated at the Brazilian National Cancer Institute.

机构信息

Department of Urology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.

出版信息

Int Braz J Urol. 2012 Mar-Apr;38(2):185-94. doi: 10.1590/s1677-55382012000200006.

Abstract

PURPOSE

We evaluated the role of several prognostic factors in predicting death and/or progressive disease in patients with renal cell carcinoma.

MATERIALS AND METHODS

Between 2004 and 2010, 227 consecutive patients with renal cell carcinoma underwent radical nephrectomy at our Institute. All histological specimens were examined by the same pathologist. We considered certain histological parameters, including histological subtype, conventional Fuhrman grade, presence of sarcomatoid features, adrenal gland infiltration, invasion of the perinephric fat, vascular embolization, collecting system invasion, presence or absence of tumour necrosis (0 %, 1 % to 49 %, or 50 % or greater) and regional lymph node metastasis.

RESULTS

Variables significantly associated with death and/or progressive disease on univariate analysis were histological subtype (p = 0.006), Fuhrman grade (p < 0.0001), tumor necrosis (p = 0.009), perinephric fat invasion (p = 0.002), vascular embolization (p = 0.0002), presence of lymph node involvement (p < 0.002), tumor size (p = 0.0006), TNM stage (p < 0.00001) and presence of metastasis (p < 0.00001). In the multivariable model histological subtype, tumor necrosis, lymph node involvement and presence of metastasis were independent risk factors for disease-free survival (p = 0.011, 0.042, 0.025 and p < 0.0001, respectively).

CONCLUSION

Histological subtype, tumor necrosis, lymph node involvement and presence of metastasis proved to be independent prognostic factors for disease-free survival. Therefore, the presence and rate of tumor necrosis should always be informed by the pathologist and lymphadenectomy should be performed in all patients.

摘要

目的

我们评估了几个预后因素在预测肾细胞癌患者死亡和/或进展性疾病中的作用。

材料与方法

2004 年至 2010 年期间,我院对 227 例连续肾细胞癌患者进行了根治性肾切除术。所有组织学标本均由同一位病理学家进行检查。我们考虑了某些组织学参数,包括组织学亚型、传统的 Fuhrman 分级、肉瘤样特征的存在、肾上腺浸润、肾周脂肪浸润、血管栓塞、集合系统浸润、肿瘤坏死的存在或不存在(0%、1%至 49%或 50%或更多)以及区域淋巴结转移。

结果

单因素分析中与死亡和/或进展性疾病显著相关的变量是组织学亚型(p=0.006)、Fuhrman 分级(p<0.0001)、肿瘤坏死(p=0.009)、肾周脂肪浸润(p=0.002)、血管栓塞(p=0.0002)、淋巴结受累(p<0.002)、肿瘤大小(p=0.0006)、TNM 分期(p<0.00001)和转移(p<0.00001)。在多变量模型中,组织学亚型、肿瘤坏死、淋巴结受累和转移是无病生存率的独立危险因素(p=0.011、0.042、0.025 和 p<0.0001)。

结论

组织学亚型、肿瘤坏死、淋巴结受累和转移被证明是无病生存率的独立预后因素。因此,病理学家应始终告知肿瘤坏死的存在和程度,并且应在所有患者中进行淋巴结切除术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验